James Investment Research’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.24M Sell
60,682
-5,088
-8% -$356K 0.5% 53
2025
Q1
$4.83M Sell
65,770
-465
-0.7% -$34.2K 0.61% 45
2024
Q4
$4.34M Sell
66,235
-16,853
-20% -$1.1M 0.52% 50
2024
Q3
$6.47M Sell
83,088
-528
-0.6% -$41.1K 0.75% 40
2024
Q2
$6.52M Sell
83,616
-11,222
-12% -$875K 0.78% 38
2024
Q1
$6.43M Sell
94,838
-9,194
-9% -$623K 0.76% 40
2023
Q4
$7.01M Sell
104,032
-890
-0.8% -$59.9K 0.88% 34
2023
Q3
$7.11M Sell
104,922
-356
-0.3% -$24.1K 0.94% 28
2023
Q2
$7.53M Sell
105,278
-679
-0.6% -$48.6K 0.96% 31
2023
Q1
$7.35M Buy
105,957
+2,462
+2% +$171K 0.97% 30
2022
Q4
$7.02M Sell
103,495
-3,087
-3% -$209K 0.98% 28
2022
Q3
$5.85M Buy
106,582
+941
+0.9% +$51.6K 0.83% 35
2022
Q2
$6.98M Sell
105,641
-960
-0.9% -$63.4K 0.93% 29
2022
Q1
$7.07M Sell
106,601
-19,004
-15% -$1.26M 0.74% 38
2021
Q4
$7.32M Sell
125,605
-5,399
-4% -$314K 0.67% 47
2021
Q3
$7.87M Sell
131,004
-9,482
-7% -$569K 0.73% 47
2021
Q2
$8.42M Sell
140,486
-484
-0.3% -$29K 0.72% 51
2021
Q1
$7.01M Sell
140,970
-25,661
-15% -$1.28M 0.64% 55
2020
Q4
$8.33M Sell
166,631
-12,659
-7% -$633K 0.75% 39
2020
Q3
$9.83M Buy
179,290
+87,705
+96% +$4.81M 0.91% 32
2020
Q2
$4.84M Buy
91,585
+91,542
+212,888% +$4.84M 0.45% 73
2020
Q1
$2K Buy
+43
New +$2K ﹤0.01% 438
2019
Q2
Sell
-250
Closed -$10K 677
2019
Q1
$10K Buy
+250
New +$10K ﹤0.01% 737
2017
Q1
Sell
-35
Closed -$1K 651
2016
Q4
$1K Hold
35
﹤0.01% 538
2016
Q3
$1K Hold
35
﹤0.01% 541
2016
Q2
$1K Buy
+35
New +$1K ﹤0.01% 506